Delivery Order SPE2DB22D1017-SPE2DB25FE7NR

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,116.74 firm-fixed-price delivery order is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,729.03 firm fixed price delivery order is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, with a completion date of August 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $8,686.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,248,680 units of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,289.97 firm fixed-price delivery order is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty pharmaceutical product. The contract has a period of performance through January 8, 2025 and was not designated as a set-aside award. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,687.80 firm-fixed-price delivery order is for NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 16, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,845.99 Firm Fixed Price delivery order covers the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.26, is a delivery order for 4560594234 NORDITROPIN FLEXPRO 30 MG/3 ML 3ML medical products. The contract has a firm fixed price and an ultimate completion date of April 17, 2023. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,783.15 firm fixed-price delivery order is for the supply of NORDITROPIN FLEXPRO 5 MG/1.5 1.5ML medical products, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.69, is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,422.46 firm fixed-price delivery order is for the supply of 4560317906 - NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, with a completion date of March 21, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7NR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,687.80 firm fixed price delivery order is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML products. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. This contract award was not designated as a set-aside.

Generated 1/17/25, 9:01 AM